Publication | Open Access
High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries.
111
Citations
41
References
1996
Year
ImmunologyImmune RegulationReceptor AntagonistsHigh Affinity TypeImmunologic MechanismAntigen ProcessingPeptide ScienceImmunotherapyImmune SystemInflammationAutoimmune DiseaseAllergyAutoimmunityRecombinant Peptide LibrariesPharmacologyCytokinePeptide LibraryPeptide TherapeuticMedicineIl-1-driven ResponsesHigh AffinityIl-1 Receptor
Two families of peptides that specifically bind the extracellular domain of the human type I interleukin I (IL-1) receptor were identified from recombinant peptide display libraries. Peptides from one of these families blocked binding of IL-lalpha to the type I IL-1 receptor with IC50 values of 45-140 microM. Affinity-selective screening of variants of these peptides produced ligands of much higher affinity (IC50 approximately 2 nM). These peptides block IL-1-driven responses in human and monkey cells; they do not bind the human type II IL-1 receptor or the murine type I IL-1 receptor. This is the first example (that we know of) of a high affinity peptide that binds to a cytokine receptor and acts as a cytokine antagonist.
| Year | Citations | |
|---|---|---|
Page 1
Page 1